DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

Subtle Medical closes RSNA with CE mark and FDA clearance of PET AI solution Speeds up scans by factor of four, enhanced image quality

Siemens unveils syngo Virtual Cockpit software for CT, MR and PET at RSNA Offers remote expert technicians when needed

South African NTP Radioisotopes facility reopens following year-long closure Will help alleviate worldwide shortages of Mo-99 and other isotopes

Total-body PET scanner produces landmark human images First ever simultaneously captured 3-D image of the entire human body

Dr. Bernhard Sixt Edinburgh Molecular Imaging appoints as new Chief Executive Officer

TeamBest companies to acquire ABT Molecular Imaging, launch Best ABT Bringing greater expertise to smaller cyclotron technology

Missouri reactor becomes sole US domestic source of I-131 A vital radioisotope in the fight against thyroid cancer and hyperthyroidism

Cardinal Health to distribute IRE ELiT's 68-Ga generators Aiming to alleviate access shortages with Galli Eo generators

Zionexa partners with Columbia PET Center on development of EstroTep Identifies estrogen receptor status to diagnose metastatic breast cancer

Canada to build medical isotope research and development center Will act as a regional source for isotopes, including Tc-99m

New imaging diagnosis for cardiac sarcoidosis

Fatty diet may improve diagnosis of lethal heart condition with PET/CT

by John W. Mitchell , Senior Correspondent
Researchers at the University of Illinois at Chicago (UIC) think they have found a much better way to find a sneaky condition that disproportionately kills African Americans.

"So far, active cardiac sarcoidosis (CS) has been a diagnostic challenge to physicians and scientists and is a potentially lethal disease, posing threats to patients," Dr. Yang Lu, lead author and chief, nuclear medicine & PT/CT, UIC, told HCB News. "Clinically, the presentation of CS is nonspecific and can range from asymptomatic, to chest pain, to abnormal EKG, to sudden death."

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



According to Lu, until this study, which has just been published online at Clinical Nuclear Medicine, there was no well-accepted, "good" imaging test to diagnose CS. The condition is especially prevalent in African Americans. Past diagnosis has been made by a combination of several diagnostic tests, but is often ambiguous.

In the study, patients were instructed to eat a high fat and protein, low sugar and carbohydrate diet for 72 hours before receiving a hybrid radio tracer (fludeoxyglucose or FDG) under PET/CT scan. The FDG collected in high-metabolic cells that use lots of sugar for energy, including cancer cells and cells affected by inflammation, such as that caused by CS.

Sarcoidosis is an inflammatory disease that attacks multiple organs. These include the lymph nodes, lungs and heart. The heart strain associated with CS can be deadly, and is particularly difficult to diagnose.

Lu said that when they started the study, patients were put on the diet for 24 hours. But this protocol only yielded clearer CS indications in about half the studies. Then a patient arrived a day late.

"The patient had been following the high-fat, low-sugar diet for two days at that point instead of the usual 24 hours," Lu said.

When they scanned the patient, the areas where the heart picked up the FDG were much clearer, and showed active CS. These findings were consistent with the abnormal CS findings from the patient's MR scan. Based on that patient, they set the dietary protocol at 72 hours.

When the team compared study results of 215 tests they found that 42 percent of the patients on the 24-hour protocol had "indeterminate" results. However, only four percent of the patients on the 72-hour protocol had indeterminate results. For the other 96 percent of patients, the radiologists were able to say with a high degree of confidence whether or not the patients suffered from CS.

"This protocol is simple and straightforward [and] might change the way we use FDG PET/CT for a CS diagnosis," Lu said.

Back to HCB News
  Pages: 1

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED